Reverse Medical Corporation

20 articles about Reverse Medical Corporation

• Covidien plc Snags Privately Held Reverse Medical Corporation, Terms Not Disclosed

  8/25/2014

• Reverse Medical Corporation Announces FDA IDE Approval For The BARREL® Vascular Reconstruction Device For The Treatment Of Intracranial Bifurcation Aneurysms

  4/15/2014

• Reverse Medical Corporation Announces CE Mark And Initial Clinical Experience With The UNO™ Neurovascular Embolization System For Intracranial Use

  2/18/2014

• Reverse Medical Corporation Announces New Patent For The Micro Vascular Plug (MVP®)

  2/5/2014

• Reverse Medical Corporation's BARREL Vascular Reconstruction Device Wins CE Mark Approval

  12/19/2013

• Reverse Medical Corporation Announces FDA 510k Clearance Of The MVP®-5 Micro Vascular Plug For Peripheral Embolization

  12/10/2013

• Reverse Medical Corporation Announces Worldwide Regulatory Approvals and Initial Clinical Experience With the ReVerse® 21 and 27 Microcatheters for Neurovascular Indications

  10/29/2013

• Reverse Medical Corporation Announces FDA 510k Clearance of the MVP™ Micro Vascular Plug for Peripheral Embolization

  8/21/2013

• Reverse Medical Corporation Touts CE Mark in Europe, Distribution Deal in Japan

  6/13/2013

• Reverse Medical Corporation Announces Strategic Alliance in Japan

  6/11/2013

• Reverse Medical Corporation Receives CE Mark MVP™ Micro Vascular Plug System

  5/14/2013

• Reverse Medical Corporation Announces Sale of its Neurovascular Guide Catheter Business to Covidien

  1/25/2012

• Reverse Medical Corporation Receives CE Mark Approval for the ReFlex(TM) A+ Catheter for Intracranial Distal Access and Aspiration

  4/5/2011

• Reverse Medical Corporation Receives CE Mark Approval for the RePort Guide Catheter System for Intracranial Access and Therapeutic Microcatheter Support during Neuro Endovascular Procedures

  7/6/2010

• Reverse Medical Corporation Announces Strategic Alliance in Asia With Getz Bros. & Company, Inc.

  4/6/2010

• Reverse Medical Corporation Successfully Completes Series B Financing; Raises $14 Million

  3/30/2010

• Reverse Medical Corporation Achieves Milestone of Human Use with the ReStore(TM) Microcatheter in Acute Ischemic Stroke

  10/8/2009

• Reverse Medical Corporation Receives FDA IDE Clinical Study Approval for the ReStoreTM Microcatheter

  9/25/2009

• Reverse Medical Corporation Receives US FDA 510k Clearance for the ReCruitTM Microcatheter for Use Including Neuro Interventional Procedures

  8/17/2009

• Reverse Medical Corporation Receives CE Mark Clearance for the ReStore(TM) Microcatheter for Blood Flow Restoration in Acute Ischemic Stroke Patients

  8/13/2009